In short, our meta-analysis included 40 eligible articles, among which 20 articles were analyzed for the frequency of BRCA1 promoter methylation in breast cancers compared with non-cancer controls, and 30 articles were analyzed for the association between BRCA1 promoter methylation and clinicopathological features. This evidence concerns the gene BRCA1 and breast carcinoma.